MedTrace Logo

mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)

NCT02897141 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-03-26

Study results available
· View outcomes & findings →

Summary

The goal of this study is to facilitate the dissemination and implementation of patient centered outcomes research using mHealth technology to improve self-management of adverse symptoms in persons living with HIV/AIDS (PLWH). Symptom management in PLWH is especially important because the US HIV epidemic continues to exact a huge toll, especially among Agency for Healthcare Research and Quality (AHRQ) priority populations including racial, ethnic, and sexual minorities and low-income persons. The incorporation of HIV symptom management strategies into patients' lives through the use of mHealth technologies has the potential to advance the effective dissemination and implementation of patient centered outcomes research findings.

Conditions

  • HIV (Human Immunodeficiency Virus)

Interventions

DEVICE

Health Management App with symptom strategies

The mVIP group will receive a Health Management App with symptom strategies. A mobile app which includes symptom strategies from the UCSF symptom management manual.

DEVICE

Control App

The attention control group will receive an app which asked them about their symptoms but did not provide symptoms strategies

Sponsors & Collaborators

Principal Investigators

  • Rebecca Schnall, PhD, MPH, RN-BC, FAAN · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-12
Primary Completion
2017-06-08
Completion
2017-06-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02897141 on ClinicalTrials.gov